submissions – Page 16

Audit trail gaps identified during FDA inspection – evidence package for inspectors

Managing Audit Trail Gaps Found During FDA Inspections: An Actionable Playbook In the evolving landscape of pharmaceutical manufacturing and quality control, audit trail gaps during FDA inspections have become a…

Shared user credentials during internal audit – evidence package for inspectors

Addressing Shared User Credentials During Internal Audit: An Evidence Package for Inspectors In the pharmaceutical manufacturing and quality landscape, the importance of robust data integrity systems cannot be understated. The…

Audit trail gaps identified during system validation – preventing escalation to warning letter

Playbook for Managing Audit Trail Gaps in System Validation to Avoid Warning Letters Audit trail gaps identified during system validation can pose serious challenges in the pharmaceutical manufacturing environment. Such…

Manual data transcription without verification during internal audit – evidence package for inspectors

Addressing the Risks of Unverified Manual Data Transcription During Internal Audits In the pharmaceutical industry, data integrity is paramount, particularly during internal audits. One of the critical failure modes in…

Inadequate DI governance during data review – evidence package for inspectors

Managing Inadequate Data Integrity Governance in Data Reviews: A Playbook for Pharma Professionals As the complexity of pharmaceutical manufacturing increases, maintaining data integrity (DI) during data reviews has become a…

Inadequate DI governance during laboratory walkthrough – preventing escalation to warning letter

Addressing Inadequate Data Integrity Governance in Laboratory Walkthroughs to Avoid Regulatory Escalation In the highly regulated pharmaceutical manufacturing and laboratory environments, maintaining data integrity is crucial. Inadequate data governance during…

Manual data transcription without verification during internal audit – CAPA effectiveness checks

Playbook for Managing Manual Data Transcription Risks During Internal Audits In the fast-paced world of pharmaceutical manufacturing and quality control, data integrity is paramount. Inadequate processes during internal audits, particularly…

Manual data transcription without verification during system validation – remediation roadmap regulators expect

Remediation Playbook for Unverified Manual Data Transcription in System Validation In the pharmaceutical manufacturing sector, the integrity and accuracy of data are paramount. Instances where manual data transcription occurs without…

Repeat data integrity lapses during system validation – CAPA effectiveness checks

Addressing Recurring Data Integrity Issues in System Validation: A Comprehensive CAPA Playbook Data integrity failures during system validation are critical issues that can jeopardize product quality and regulatory compliance. Such…

Shared user credentials during laboratory walkthrough – preventing escalation to warning letter

Creating a Playbook for Addressing Shared User Credentials During Laboratory Walkthroughs In the pharmaceutical industry, maintaining data integrity is paramount to ensuring compliance with regulatory standards such as FDA, EMA,…

Audit trail gaps identified during data review – CAPA effectiveness checks

Addressing Audit Trail Gaps Detected During Data Review: A Comprehensive Playbook In the highly regulated pharmaceutical manufacturing environment, audit trails provide critical evidence of compliance with Good Data Practices (GDP)…

Audit trail gaps identified during system validation – evidence package for inspectors

“`html Addressing Gaps in Audit Trail During System Validation: A Comprehensive Guide for Pharma Professionals As pharmaceutical companies increasingly rely on automated systems for documentation and data management, the risk…